Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
55 shown of 9,268 total abstracts
  1. Abstract 90222026-04-03 · 20:00 CT · Arie Crown Theater
    Quality of life outcomes with Tecentriq in patients with NSCLC
    J. Cortes, F. Andre, S. Modi, et al. · Royal Marsden Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  2. Abstract 90232026-04-03 · 20:30 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-159
    S. Peters, S. Antonia, C. Robert, et al. · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  3. Abstract 94372026-04-04 · 16:30 CT · S406
    Quality of life outcomes with Tagrisso in patients with NSCLC
    M. Reck, J. Brahmer, S. Antonia, et al. · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  4. Abstract 91622026-04-04 · 20:45 CT · Arie Crown Theater
    DESTINY-Breast-218: Enhertu (trastuzumab deruxtecan) adjuvant in NSCLC
    H. Rugo, S. Modi, C. Saura, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  5. Abstract 96922026-04-02 · 18:15 CT · S100A
    Real-world effectiveness of Enhertu vs standard of care in NSCLC
    M. Krop, R. Herbst, S. Tolaney, et al. · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  6. Abstract 99332026-04-01 · 16:30 CT · E450
    Real-world effectiveness of Tagrisso vs standard of care in NSCLC
    N. Rizvi, H. Rugo, P. Schmid, et al. · Royal Marsden Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  7. Abstract 97902026-04-02 · 14:15 CT · Hall B1
    KEYNOTE-171: Keytruda (pembrolizumab) 2L in NSCLC
    A. Spira, S. Peters, J. Brahmer, et al. · Massachusetts General Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  8. Abstract 96162026-04-05 · 13:15 CT · E450
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-953
    J. Brahmer, H. Borghaei, J. Cortes, et al. · Massachusetts General Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  9. Abstract 98522026-04-02 · 16:15 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-63
    S. Modi, M.C. Garassino · National Cancer Center Japan
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  10. Abstract 97082026-04-04 · 16:30 CT · S406
    PACIFIC-135: Imfinzi (durvalumab) 1L in SCLC
    C. Saura, T. Mok, N. Rizvi · Massachusetts General Hospital
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  11. Abstract 94952026-04-01 · 15:30 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-104
    S. Peters, H. Borghaei, C. Robert, et al. · University of Chicago
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  12. Abstract 97552026-04-03 · 16:15 CT · Hall B1
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-695
    H. Borghaei, S. Peters · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  13. Abstract 93412026-04-04 · 14:00 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-877
    T. Mok, F. Andre, L. Paz-Ares · MD Anderson Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  14. Abstract 99712026-04-03 · 14:15 CT · Hall B1
    FLAURA-690: Tagrisso (osimertinib) 2L in NSCLC
    L. Paz-Ares, R. Herbst, J. Cortes · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  15. Abstract 92492026-04-03 · 19:15 CT · Hall B1
    Quality of life outcomes with Opdivo in patients with NSCLC
    C. Saura, S. Tolaney, S. Antonia · Mayo Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  16. Abstract 97182026-04-05 · 21:00 CT · E450
    FLAURA-577: Tagrisso (osimertinib) 1L in NSCLC
    R. Herbst, A. Spira, G. Curigliano, et al. · Royal Marsden Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  17. Abstract 95272026-04-04 · 13:30 CT · Arie Crown Theater
    FLAURA-678: Tagrisso (osimertinib) 1L in NSCLC
    F. Andre, H. Borghaei, M. Reck, et al. · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  18. Abstract 90842026-04-05 · 19:15 CT · S100A
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-824
    C. Robert, L. Paz-Ares, S. Antonia, et al. · Massachusetts General Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  19. Abstract 91222026-04-05 · 14:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-670 study)
    C. Robert, L. Paz-Ares · Johns Hopkins Kimmel Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  20. Abstract 98022026-04-04 · 21:30 CT · Hall B1
    Long-term follow-up of Enhertu maintenance for NSCLC: DESTINY-Breast-231
    F. Andre, J. Brahmer, T. Mok · Royal Marsden Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  21. Abstract 99262026-04-04 · 18:15 CT · S100A
    Quality of life outcomes with Keytruda in patients with NSCLC
    G. Curigliano, A. Spira, S. Tolaney, et al. · Karolinska Institute
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  22. Abstract 95802026-04-02 · 19:15 CT · Arie Crown Theater
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-251
    A. Spira, G. Curigliano, R. Herbst, et al. · University of Chicago
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  23. Abstract 99332026-04-05 · 16:00 CT · E450
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-893 study)
    S. Tolaney, A. Spira, T. Mok, et al. · Johns Hopkins Kimmel Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  24. Abstract 98392026-04-02 · 20:45 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-520 study)
    J. Brahmer, F. Andre, E. Winer · Chinese University of Hong Kong
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  25. Abstract 96702026-04-03 · 18:30 CT · S406
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-256 study)
    R. Herbst, S. Antonia, C. Saura · Chinese University of Hong Kong
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  26. Abstract 90822026-04-02 · 19:30 CT · S100A
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-102
    M. Krop, C. Saura, H. Rugo · University of Chicago
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  27. Abstract 92422026-04-05 · 18:30 CT · S406
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-40
    H. Borghaei, N. Rizvi, G. Curigliano, et al. · Institut Gustave Roussy
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  28. Abstract 97022026-04-02 · 13:30 CT · Hall B1
    Long-term follow-up of Imfinzi maintenance for NSCLC: PACIFIC-963
    S. Peters, S. Modi, N. Rizvi, et al. · Johns Hopkins Kimmel Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  29. Abstract 96412026-04-01 · 16:45 CT · S406
    Quality of life outcomes with Imfinzi in patients with SCLC
    S. Antonia, S. Modi · University of Chicago
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  30. Abstract 93522026-04-02 · 18:45 CT · S100A
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-319
    H. Borghaei, E. Winer, G. Curigliano, et al. · Memorial Sloan Kettering Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  31. Abstract 98962026-04-05 · 21:30 CT · Hall B1
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-977 study)
    M. Reck, S. Tolaney · Stanford Cancer Institute
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  32. Abstract 90222026-04-04 · 16:45 CT · S100A
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-190 study)
    P. Schmid, N. Rizvi · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  33. Abstract 90872026-04-02 · 14:15 CT · S100A
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-166
    L. Paz-Ares, F. Andre · UCSF Helen Diller Family Comprehensive Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  34. Abstract 95702026-04-02 · 19:00 CT · Hall B1
    Real-world effectiveness of Imfinzi vs standard of care in SCLC
    S. Modi, M. Krop · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  35. Abstract 99852026-04-03 · 13:00 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-432 study)
    S. Peters, G. Curigliano, H. Rugo, et al. · Memorial Sloan Kettering Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  36. Abstract 98022026-04-03 · 14:00 CT · Hall B1
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-703 study)
    M. Krop, G. Curigliano, C. Robert · Memorial Sloan Kettering Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  37. Abstract 90422026-04-04 · 14:00 CT · E450
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-941
    M. Krop, E. Winer, S. Modi, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  38. Abstract 92522026-04-05 · 21:45 CT · Arie Crown Theater
    Long-term follow-up of Opdivo 1L for NSCLC: CheckMate-856
    J. Cortes, F. Andre, P. Schmid · Stanford Cancer Institute
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  39. Abstract 91712026-04-03 · 19:30 CT · S100A
    FLAURA-220: Tagrisso (osimertinib) 1L in NSCLC
    M. Reck, C. Saura, S. Antonia · MD Anderson Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  40. Abstract 98862026-04-03 · 18:30 CT · Arie Crown Theater
    IMpower-10: Tecentriq (atezolizumab) maintenance in NSCLC
    M. Krop, M. Reck, T. Mok, et al. · MD Anderson Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  41. Abstract 91432026-04-02 · 20:00 CT · Hall B1
    Quality of life outcomes with Keytruda in patients with SCLC
    N. Rizvi, J. Brahmer, H. Borghaei, et al. · University of Chicago
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  42. Abstract 97032026-04-04 · 15:45 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-491 study)
    F. Andre, C. Robert, A. Spira · Vall d'Hebron Institute of Oncology
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  43. Abstract 92632026-04-05 · 16:45 CT · E450
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-774 study)
    E. Winer, H. Borghaei, P. Schmid · Mayo Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  44. Abstract 98362026-04-01 · 18:00 CT · E450
    Long-term follow-up of Opdivo adjuvant for NSCLC: CheckMate-951
    M. Krop, J. Cortes, E. Winer · Chinese University of Hong Kong
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  45. Abstract 93552026-04-02 · 14:00 CT · E450
    FLAURA-515: Tagrisso (osimertinib) neoadjuvant in NSCLC
    S. Modi, M. Reck · Institut Gustave Roussy
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  46. Abstract 94512026-04-03 · 21:30 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-365
    C. Robert, M. Reck · University of Chicago
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  47. Abstract 95352026-04-03 · 14:15 CT · S406
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-770 study)
    M. Reck, N. Rizvi, M.C. Garassino, et al. · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  48. Abstract 90602026-04-05 · 19:30 CT · S100A
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-503 study)
    N. Rizvi, P. Schmid, C. Saura, et al. · Peter MacCallum Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  49. Abstract 92942026-04-04 · 14:30 CT · S100A
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-514 study)
    H. Borghaei, R. Herbst · MD Anderson Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  50. Abstract 96922026-04-02 · 20:30 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-121
    H. Borghaei, M.C. Garassino, H. Rugo, et al. · Institut Gustave Roussy
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  51. Abstract 99022026-04-02 · 15:45 CT · S406
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-876
    L. Paz-Ares, S. Peters, R. Herbst · Institut Gustave Roussy
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  52. Abstract 95282026-04-04 · 20:30 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-162 study)
    H. Rugo, M. Krop, N. Rizvi, et al. · Vall d'Hebron Institute of Oncology
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  53. Abstract 97682026-04-03 · 15:30 CT · S100A
    PACIFIC-828: Imfinzi (durvalumab) 3L+ in SCLC
    H. Rugo, S. Modi, M. Reck, et al. · Princess Margaret Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  54. Abstract 93692026-04-04 · 16:00 CT · S406
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-51
    C. Saura, S. Antonia, H. Borghaei · Institut Gustave Roussy
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  55. Abstract 91842026-04-02 · 16:45 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-518
    S. Antonia, T. Mok, J. Brahmer, et al. · Royal Marsden Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.